Pieniaźek D, Pronicka E, Socha J, Pawlawska J, Miloszewska E, Woźniewicz B, Klimaszewski J, Moszczyńska A, Urbanek M
Hepatogastroenterology. 1985 Oct;32(5):235-9.
The evaluation of hepatic degradation of glycogen in patients with different chronic liver diseases was carried out on the basis of: a) specific activities of hepatic enzymes involved in catabolism of glycogen; b) level of glycogen in liver biopsies; c) concentration of glucose and cAMP in serum after the intravenous administration of glucagon. In 13 out of 35 patients investigated the activity of glucose-6-phosphatase was decreased to 14-50% of the control value. In the livers of 3 patients glycogen phosphorylase activity was decreased to 10% of the control value. In patients with the significantly low activities of hepatic glucose-6-phosphatase and phosphorylase a, however, normal catabolism of glycogen in the liver was observed, neither hypoglycemia nor abnormal glycogen storage in liver biopsies nor abnormal response to glucagon being found. In the group of patients with decreased and normal activities of glucose-6-phosphatase and phosphorylase a, biochemical parameters in the serum (i.e. markers of liver damage) were not detectable. Possible causes of the selective and asymptomatic decrease in the activities of glucose-6-phosphatase and phosphorylase a are discussed.
a)参与糖原分解代谢的肝脏酶的比活性;b)肝活检中糖原水平;c)静脉注射胰高血糖素后血清中葡萄糖和环磷酸腺苷(cAMP)的浓度。在35例接受调查的患者中,有13例葡萄糖-6-磷酸酶活性降至对照值的14% - 50%。3例患者肝脏中糖原磷酸化酶活性降至对照值的10%。然而,在肝脏葡萄糖-6-磷酸酶和磷酸化酶a活性显著降低的患者中,观察到肝脏糖原正常分解代谢,未发现低血糖、肝活检中糖原储存异常或对胰高血糖素的异常反应。在葡萄糖-6-磷酸酶和磷酸化酶a活性降低及正常的患者组中,血清中的生化参数(即肝损伤标志物)未检测到。文中讨论了葡萄糖-6-磷酸酶和磷酸化酶a活性选择性且无症状降低的可能原因。